Electronic Cigarettes
2014; Lippincott Williams & Wilkins; Volume: 129; Issue: 19 Linguagem: Catalão
10.1161/circulationaha.114.008545
ISSN1524-4539
AutoresRachel A. Grana, Pamela M. Ling, Neal L. Benowitz, Stanton A. Glantz,
Tópico(s)Obesity, Physical Activity, Diet
ResumoHomeCirculationVol. 129, No. 19Electronic Cigarettes Free AccessResearch ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticlePDF/EPUBElectronic Cigarettes Rachel A. Grana, PhD, MPH, Pamela M. Ling, MD, MPH, Neal Benowitz, MD and Stanton Glantz, PhD Rachel A. GranaRachel A. Grana From the Center for Tobacco Control Research and Education, Department of Medicine, Helen Diller Family Comprehensive Cancer Center Tobacco Control Program, University of California, San Francisco, San Francisco. , Pamela M. LingPamela M. Ling From the Center for Tobacco Control Research and Education, Department of Medicine, Helen Diller Family Comprehensive Cancer Center Tobacco Control Program, University of California, San Francisco, San Francisco. , Neal BenowitzNeal Benowitz From the Center for Tobacco Control Research and Education, Department of Medicine, Helen Diller Family Comprehensive Cancer Center Tobacco Control Program, University of California, San Francisco, San Francisco. and Stanton GlantzStanton Glantz From the Center for Tobacco Control Research and Education, Department of Medicine, Helen Diller Family Comprehensive Cancer Center Tobacco Control Program, University of California, San Francisco, San Francisco. Originally published13 May 2014https://doi.org/10.1161/CIRCULATIONAHA.114.008545Circulation. 2014;129:e490–e492IntroductionElectronic cigarettes (E-cigarettes) are devices that deliver nicotine to a user by heating and converting to an aerosol a liquid mixture typically composed of propylene glycol, vegetable glycerin, flavoring chemicals, and nicotine1 (Figure). E-cigarette use doubled in just 1 year among both adults and children, from 3.4% to 6.2% in adults (2010–2011) and 3.3% to 6.8% in youth (2011–2012), with high levels of dual use with tobacco cigarettes.1 Although most youth using e-cigarettes are dual users, up to one third of adolescents who tried an e-cigarette have never smoked a conventional cigarette, indicating that some youth are initiating use of the addictive drug nicotine with e-cigarettes.1Download figureDownload PowerPointFigure. Electronic cigarettes (e-cigarettes) come in many forms and are often not called e-cigarettes by users. Other names include e-hookah, shisha pens, and vape pens (reproduced from Grana et al).1E-cigarettes are aggressively advertised on television, on the radio, on the Internet, and in magazines, and e-cigarettes companies sponsor sporting events and music festivals.1 E-cigarette advertising is very similar to cigarette advertising from the 1950s and 1960s, and e-cigarette products come in kid-friendly flavors (including grape, chocolate, bubble gum, and gummy bear). E-cigarette advertising promises to deliver nicotine, the addictive drug in cigarettes, without the toxic chemicals produced by burning tobacco cigarettes and without exposing others to secondhand smoke. Marketing for e-cigarettes often describes them as emitting only "harmless water vapor."1 This message is often coupled with claims that one can "smoke" anytime and anywhere, often with a list of places where tobacco smoking is restricted, including restaurants, bars, offices, and airplanes.What Is Known About E-Cigarettes?The claim that e-cigarettes emit only harmless water vapor is not true.1 Although e-cigarette aerosol delivers lower levels of many toxins than cigarette smoke, the aerosol still contains nicotine, ultrafine particles, other toxic chemicals, and carcinogens. Users inhale a heated propylene glycol or glycerin-based solution for which there are no long-term studies. A short-term exposure study showed that 5 minutes of e-cigarette use resulted in a significant increase in airway flow resistance, which, although of unknown clinical significance, does not support the claim the product is harmless.2There is poor correlation between labeled and actual nicotine content, as well as varying levels of other chemicals and toxicants in the e-liquid and aerosol.1 Nonsmokers (persons who do not use tobacco cigarettes or e-cigarettes) who are exposed to the exhaled, or secondhand, e-cigarette aerosol have measurable levels of the nicotine metabolite cotinine in their blood.1If someone switched completely from tobacco cigarettes to only using e-cigarettes, he or she would inhale fewer toxic chemicals to get the same dose of nicotine. However, most e-cigarette users continue to smoke tobacco cigarettes (dual use). Because the effects of smoking on the heart, blood, and blood vessels occur at very low levels of smoking (and even secondhand smoke),3 e-cigarette users are unlikely to experience any benefit in terms of reduced rates of cardiovascular disease. Even cancer risk, which depends to some extent on smoking intensity (cigarettes per day), depends in large part on duration (years of smoking).4,5 Thus, use of electronic cigarettes to cut down on number of cigarettes smoked per day is likely to have much smaller beneficial effects on overall survival than quitting smoking completely.What Is Known About E-Cigarettes and Smoking Cessation?E-cigarettes have not been approved in the United States as cessation aids, and as of March 2014, none of the e-cigarette companies had submitted applications to the US Food and Drug Administration to approve them as cessation aids.Nevertheless, many companies directly or indirectly market the products as helpful for smoking cessation. Many news stories report testimonials from people who say that e-cigarettes helped them quit smoking.Studies with convenience samples of e-cigarette users show that people use e-cigarettes to try to quit smoking cigarettes.1 In a randomized trial comparing the effects of the use of nicotine e-cigarette, nonnicotine e-cigarette, and a nicotine patch, neither nicotine-containing or nonnicotine e-cigarettes outperformed the patch, although the users reported liking e-cigarettes better than the patch. As of March 2014, 5 population-based studies had examined the relationship between e-cigarette use and quitting smoking. Because these studies did not measure whether people were using e-cigarettes as a smoking cessation aid or other reasons for use such as to circumvent smoke-free laws, they did not directly test the efficacy of e-cigarettes as smoking cessation aids. These 5 studies taken together, however, showed that smokers who used e-cigarettes were less likely to quit smoking than smokers who did not use e-cigarettes.1What Can Clinicians Do When Patients Want to Use E-Cigarettes to Quit Smoking?A patient who asks a clinician about using the e-cigarette for quitting smoking may be signaling readiness to quit smoking. It is most important to support the patient's quit attempt and to try to ensure that any advice given does not undermine the patient's motivation to quit smoking. Use the opportunity to learn about the patient's motivation to quit, to discuss past experience with cessation, and to encourage and facilitate evidence-based treatment such as smoking cessation counseling (including use of a tobacco telephone quit line), approved nicotine replacement therapies (eg, patch, gum, or inhaler), and oral nonnicotine medications such as Chantix (varenicline) or Zyban (bupropion),6 particularly if evidence-based treatments have not been used correctly in the past.If someone is already using e-cigarettes to quit smoking, support the quit attempt, and encourage him or her to quit all tobacco cigarette use, emphasizing the lack of reduction in health risks from dual use. Inform him or her that e-cigarettes are not approved by the US Food and Drug Administration for smoking cessation. The limited research published to date has not proven that electronic cigarettes are effective smoking cessation aids. Inform patients that e-cigarettes are unregulated and that users cannot be sure what they are exposed to. Given the lack of knowledge about long-term risks and potential harms, patients should also be urged to set a quit date for their e-cigarette use.Policy RecommendationsSmoke-free policies are a critical intervention both to protect nonsmokers and to support smoking cessation attempts. To avoid reversing the effectiveness of these policies, e-cigarettes should not be used anyplace where smoking cigarettes is not allowed (including in homes that are smoke-free). There is no reason to reintroduce toxins into clean indoor air environments. As of March 2014, more than 100 communities (including New York, Los Angeles, San Francisco, and Chicago) and 3 states (New Jersey, North Dakota, and Utah) included e-cigarettes in their clean indoor air laws.1As of March 2014, e-cigarettes were not regulated by the US Food and Drug Administration. The product should be regulated by the US Food and Drug Administration, and therapeutic claims (eg, that they are effective for smoking cessation) should be prohibited until such time that the e-cigarette companies provide evidence that, as actually used, e-cigarettes improve cessation success. To prevent youth initiation, e-cigarette advertising should be subject to the same restrictions (including being prohibited on television and radio) as cigarette advertising, and the use of flavors should be prohibited.Sources of FundingDr Grana is supported in part by grant 21FT-0040 from the California Tobacco-Related Disease Research Program. Dr Ling is supported in part by grant CA141661 from the National Cancer Institute. Drs Benowitz and Glantz are supported in part by grant 1P50CA180890 from the US National Cancer Institute and Food and Drug Administration. The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the California Tobacco-Related Disease Research Program, the National Institutes of Health, or the US Food and Drug Administration. Dr Glantz is an American Legacy Foundation Distinguished Professor in Tobacco Control.DisclosuresDr Benowitz is a consultant to several pharmaceutical companies that market smoking cessation medications and has been a paid expert witness in litigation against the tobacco companies. The other authors report no conflicts.FootnotesThe information contained in this Circulation Cardiology Patient Page is not a substitute for medical advice, and the American Heart Association recommends consultation with your doctor or healthcare professional.Correspondence to Stanton Glantz, PhD, Professor of Medicine, Director, Center for Tobacco Control Research and Education, Co-Director, Helen Diller Family Comprehensive Cancer Center Tobacco Control Program, University of California San Francisco, 530 Parnassus, Ste 366, San Francisco, CA 94143-1390. E-mail [email protected]References1. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review.Circulation. 2014; 129:1972–1986.LinkGoogle Scholar2. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide.Chest. 2012; 141:1400–1406.CrossrefMedlineGoogle Scholar3. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking.Circulation. 2005; 111:2684–2698.LinkGoogle Scholar4. Tverdal A, Bjartveit K. Health consequences of reduced daily cigarette consumption.Tob Control. 2006; 15:472–480.CrossrefMedlineGoogle Scholar5. Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, Hartge P, Gapstur SM. 50-Year trends in smoking-related mortality in the United States.N Engl J Med. 2013; 368:351–364.CrossrefMedlineGoogle Scholar6. Fiore MTreating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline. Darby, PA: DIANE Publishing; 2008.Google Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Ananthakrishnan A, Kaplan G, Bernstein C, Burke K, Lochhead P, Sasson A, Agrawal M, Tiong J, Steinberg J, Kruis W, Steinwurz F, Ahuja V, Ng S, Rubin D, Colombel J, Gearry R, Abreu M, Ahuja V, Allez M, Ananthakrishnan A, Bemelman W, Bernstein C, Braun J, Chowers Y, Colombel J, Danese S, D'Haens G, D'Hoore A, Dignass A, Dotan I, Dubinsky M, Ekbom A, Fleshner P, Gasche C, Gassull M, Gearry R, Ghosh S, Gibson P, Griffiths A, Halfvarson J, Hanauer S, Harpaz N, Hart A, Hibi T, Kamm M, Kaplan G, Kaser A, Korelitz B, Kotze P, Koutroubakis I, Kruis W, Lakatos P, Lewis J, Lindsay J, Loftus E, Louis E, Lukas M, Magro F, Mahadevan U, Mantzaris G, Mary J, McGovern D, Moum B, Munkholm P, Neurath M, Ng S, O'Morain C, Oresland T, Panaccione R, Panes J, Panis Y, Pemberton J, Peyrin-Biroulet L, Prantera C, Rachmilewitz D, Ran Z, Reinisch W, Remzi F, Rhodes J, Riddell R, Rogler G, Rubin D, Sachar D, Sandborn W, Sands B, Sartor B, Schoelmerich J, Schreiber S, Siegel C, Siegmund B, Silverberg M, Söderholm J, Sood A, Spinelli A, Stange E, Steinwurz F, Targan S, Travis S, Turner D, Tysk C, Vatn M, Vermeire S, Watanabe M, Yamamoto T and Yamamoto-Furusho J (2022) Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus, The Lancet Gastroenterology & Hepatology, 10.1016/S2468-1253(22)00021-8, 7:7, (666-678), Online publication date: 1-Jul-2022. Karpenko M, Ovsyannikov D, Frolov P, Nikiforova T and Khandy M (2022) E-cigarette or vaping use-associated lung injury, Tuberculosis and Lung Diseases, 10.21292/2075-1230-2022-100-4-52-61, 100:4, (52-61) Catala-Valentin A, Bernard J, Caldwell M, Maxson J, Moore S, Andl C and Kaspar J (2022) E-Cigarette Aerosol Exposure Favors the Growth and Colonization of Oral Streptococcus mutans Compared to Commensal Streptococci, Microbiology Spectrum, 10.1128/spectrum.02421-21, 10:2, Online publication date: 27-Apr-2022. Park S and Lee K (2021) Association of heated tobacco product use and secondhand smoke exposure with suicidal ideation, suicide plans and suicide attempts among Korean adolescents: A 2019 national survey, Tobacco Induced Diseases, 10.18332/tid/140824, 19:September, (1-11), Online publication date: 21-Sep-2021. Prasad K and Bondy S (2021) Electronic cigarette aerosol increases the risk of organ dysfunction by enhancing oxidative stress and inflammation, Drug and Chemical Toxicology, 10.1080/01480545.2021.1972680, (1-7) Cardenas V, Ali M, Fischbach L and Nembhard W (2020) Dual use of cigarettes and electronic nicotine delivery systems during pregnancy and the risk of small for gestational age neonates, Annals of Epidemiology, 10.1016/j.annepidem.2020.08.002, 52, (86-92.e2), Online publication date: 1-Dec-2020. Morphett K, Herron L and Gartner C (2019) Protectors or puritans? Responses to media articles about the health effects of e-cigarettes, Addiction Research & Theory, 10.1080/16066359.2019.1596259, 28:2, (95-102), Online publication date: 3-Mar-2020. Owusu D, Huang J, Weaver S, Pechacek T, Ashley D, Nayak P and Eriksen M (2019) Patterns and trends of dual use of e-cigarettes and cigarettes among U.S. adults, 2015–2018, Preventive Medicine Reports, 10.1016/j.pmedr.2019.101009, 16, (101009), Online publication date: 1-Dec-2019. Chong C, Rahman A, Loonat K, Sagar R and Selinger C (2019) Current smoking habits in British IBD patients in the age of e-cigarettes, BMJ Open Gastroenterology, 10.1136/bmjgast-2019-000309, 6:1, (e000309), Online publication date: 1-Jun-2019. Cardenas V, Cen R, Clemens M, Moody H, Ekanem U, Policherla A, Fischbach L, Eswaran H, Magann E, Delongchamp R and Boysen G (2019) Use of Electronic Nicotine Delivery Systems (ENDS) by pregnant women I: Risk of small-for-gestational-age birth, Tobacco Induced Diseases, 10.18332/tid/106089, 17:May Chang Y, Lee Y, Liu C and Shelley M (2018) Patterns of e-cigarette use and self-reported health outcomes among smokers and non-smokers in the United States: A preliminary assessment, Journal of Substance Use, 10.1080/14659891.2018.1510053, 24:1, (79-87), Online publication date: 2-Jan-2019. Mohamed M, Rahman A, Jamshed S and Mahmood S (2018) Effectiveness and safety of electronic cigarettes among sole and dual user vapers in Kuantan and Pekan, Malaysia: a six-month observational study, BMC Public Health, 10.1186/s12889-018-5951-2, 18:1, Online publication date: 1-Dec-2018. Weaver S, Huang J, Pechacek T, Heath J, Ashley D, Eriksen M and Niaura R (2018) Are electronic nicotine delivery systems helping cigarette smokers quit? Evidence from a prospective cohort study of U.S. adult smokers, 2015–2016, PLOS ONE, 10.1371/journal.pone.0198047, 13:7, (e0198047) Rahman A, Nik Mohamed M and Mahmood S (2018) Nicotine Estimations in Electronic Cigarette E-Liquids Among Malaysian Marketed Samples, Analytical Chemistry Letters, 10.1080/22297928.2017.1400920, 8:1, (54-62), Online publication date: 2-Jan-2018. Luo Y, Li Q, Sun S, Zeng D and Leischow S (2018) Understanding of Users' Response to the Intervention of FDA's New Deeming Rules in Twitter the 2nd International Conference, 10.1145/3239438.3239439, 9781450363891, (1-8), . Hawkins B (2018) Electronic Cigarettes Regulation in the UK: A Case Study in Evidence Informed Policy Making Evidence Use in Health Policy Making, 10.1007/978-3-319-93467-9_7, (137-153), . Fallin-Bennett A, Lisha N and Ling P (2017) Other Tobacco Product Use Among Sexual Minority Young Adult Bar Patrons, American Journal of Preventive Medicine, 10.1016/j.amepre.2017.03.006, 53:3, (327-334), Online publication date: 1-Sep-2017. Poynton S, Sutton J, Goodall S, Margham J, Forster M, Scott K, Liu C, McAdam K, Murphy J and Proctor C (2017) A novel hybrid tobacco product that delivers a tobacco flavour note with vapour aerosol (Part 1): Product operation and preliminary aerosol chemistry assessment, Food and Chemical Toxicology, 10.1016/j.fct.2017.05.022, 106, (522-532), Online publication date: 1-Aug-2017. Jensen R, Strongin R and Peyton D (2017) Solvent Chemistry in the Electronic Cigarette Reaction Vessel, Scientific Reports, 10.1038/srep42549, 7:1, Online publication date: 1-Mar-2017. Zborovskaya Y (2017) E-Cigarettes and Smoking Cessation: A Primer for Oncology Clinicians, Clinical Journal of Oncology Nursing, 10.1188/17.CJON.54-63, 21:1, (54-63), Online publication date: 1-Feb-2017. Glasser A, Collins L, Pearson J, Abudayyeh H, Niaura R, Abrams D and Villanti A (2017) Overview of Electronic Nicotine Delivery Systems: A Systematic Review, American Journal of Preventive Medicine, 10.1016/j.amepre.2016.10.036, 52:2, (e33-e66), Online publication date: 1-Feb-2017. Hallingberg B, Fletcher A, Murphy S, Morgan K, Littlecott H, Roberts C and Moore G (2016) Do stronger school smoking policies make a difference? Analysis of the health behaviour in school-aged children survey, The European Journal of Public Health, 10.1093/eurpub/ckw093, 26:6, (964-968), Online publication date: 1-Dec-2016. Vijayaraghavan M, Schroeder S and Kushel M (2016) The effectiveness of tobacco control policies on vulnerable populations in the USA: a review, Postgraduate Medical Journal, 10.1136/postgradmedj-2014-133193, 92:1093, (670-676), Online publication date: 1-Nov-2016. Wagoner K, Cornacchione J, Wiseman K, Teal R, Moracco K and Sutfin E (2016) E-cigarettes, Hookah Pens and Vapes: Adolescent and Young Adult Perceptions of Electronic Nicotine Delivery Systems: Table 1., Nicotine & Tobacco Research, 10.1093/ntr/ntw095, 18:10, (2006-2012), Online publication date: 1-Oct-2016. Chagué F, Rochette L, Gudjoncik A, Cottin Y and Zeller M (2016) Electronic cigarettes and sports: Dangerous liaisons?, International Journal of Cardiology, 10.1016/j.ijcard.2016.04.048, 215, (400-401), Online publication date: 1-Jul-2016. Kalkhoran S, Padilla J, Neilands T and Ling P (2016) Multiple tobacco product use among young adult bar patrons in New Mexico, Preventive Medicine, 10.1016/j.ypmed.2015.11.024, 83, (16-21), Online publication date: 1-Feb-2016. Martínez-Sánchez J, Fu M, Martín-Sánchez J, Ballbè M, Saltó E and Fernández E (2015) Perception of electronic cigarettes in the general population: does their usefulness outweigh their risks?, BMJ Open, 10.1136/bmjopen-2015-009218, 5:11, (e009218), Online publication date: 1-Nov-2015. Parrott A (2015) The Psychobiological Problems of Continued Nicotine Dependency in E-Cigarette 'Vapers'. Commentary: "Electronic Cigarettes", Frontiers in Psychiatry, 10.3389/fpsyt.2015.00123, 6 Cooke W, Pokhrel A, Dowling C, Fogt D and Rickards C (2015) Acute inhalation of vaporized nicotine increases arterial pressure in young non-smokers: a pilot study, Clinical Autonomic Research, 10.1007/s10286-015-0304-z, 25:4, (267-270), Online publication date: 1-Aug-2015. Martínez-Sánchez J, Fu M, Ballbè M, Martín-Sánchez J, Saltó E and Fernández E (2015) Conocimiento y percepción de la nocividad del cigarrillo electrónico en población adulta de Barcelona, Gaceta Sanitaria, 10.1016/j.gaceta.2015.01.014, 29:4, (296-299), Online publication date: 1-Jul-2015. Orellana-Barrios M, Payne D, Mulkey Z and Nugent K (2015) Electronic Cigarettes—A Narrative Review for Clinicians, The American Journal of Medicine, 10.1016/j.amjmed.2015.01.033, 128:7, (674-681), Online publication date: 1-Jul-2015. Glasser A, Cobb C, Teplitskaya L, Ganz O, Katz L, Rose S, Feirman S and Villanti A (2015) Electronic nicotine delivery devices, and their impact on health and patterns of tobacco use: a systematic review protocol, BMJ Open, 10.1136/bmjopen-2015-007688, 5:4, (e007688-e007688), Online publication date: 29-Apr-2015. Kandel D and Kandel E (2014) The Gateway Hypothesis of substance abuse: developmental, biological and societal perspectives, Acta Paediatrica, 10.1111/apa.12851, 104:2, (130-137), Online publication date: 1-Feb-2015. Talih S, Balhas Z, Eissenberg T, Salman R, Karaoghlanian N, El Hellani A, Baalbaki R, Saliba N and Shihadeh A (2014) Effects of User Puff Topography, Device Voltage, and Liquid Nicotine Concentration on Electronic Cigarette Nicotine Yield: Measurements and Model Predictions, Nicotine & Tobacco Research, 10.1093/ntr/ntu174, 17:2, (150-157), Online publication date: 1-Feb-2015., Online publication date: 1-Feb-2015. Lessard J, Henrie J, Livingston J, Leonard K, Colder C and Eiden R (2014) Correlates of Ever Having Used Electronic Cigarettes Among Older Adolescent Children of Alcoholic Fathers, Nicotine & Tobacco Research, 10.1093/ntr/ntu148, 16:12, (1656-1660), Online publication date: 1-Dec-2014., Online publication date: 1-Dec-2014. Bhatnagar A, Whitsel L, Ribisl K, Bullen C, Chaloupka F, Piano M, Robertson R, McAuley T, Goff D and Benowitz N (2014) Electronic Cigarettes, Circulation, 130:16, (1418-1436), Online publication date: 14-Oct-2014. Arnold C (2014) Vaping and Health: What Do We Know about E-Cigarettes?, Environmental Health Perspectives, 10.1289/ehp.122-A244, 122:9, Online publication date: 1-Sep-2014. Martinez-Sanchez J, Ballbe M, Fu M, Martin-Sanchez J, Salto E, Gottlieb M, Daynard R, Connolly G and Fernandez E (2014) Electronic cigarette use among adult population: a cross-sectional study in Barcelona, Spain (2013-2014), BMJ Open, 10.1136/bmjopen-2014-005894, 4:8, (e005894-e005894), Online publication date: 25-Aug-2014. May 13, 2014Vol 129, Issue 19 Advertisement Article InformationMetrics © 2014 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.114.008545PMID: 24821830 Originally publishedMay 13, 2014 PDF download Advertisement SubjectsEthics and PolicyTreatment
Referência(s)